WeVote
Log In

Bill

Bill

S 5786

Requires certain eligible persons or entities to acquire and possess opioid antagonists

2025 Regular Session Introduced by Luis Sepúlveda

Bill S 5786 mandates certain individuals and organizations to acquire and maintain opioid antagonists, enhancing access to life-saving overdose reversal medications.

REFERRED TO HEALTH
0
WeVote Research Nonpartisan
Bill Summary · S 5786

Summary of Bill S 5786

Bill Information

  • Bill Number: S 5786
  • Title: Requires certain eligible persons or entities to acquire and possess opioid antagonists
  • Status: Referred to Health Committee
  • Introduced: March 03, 2025
  • Classification: Bill

Purpose and Intent

Bill S 5786 aims to address the ongoing opioid crisis by mandating that specific individuals and organizations obtain and maintain a supply of opioid antagonists, such as naloxone. The intent is to enhance the availability of life-saving medications that can reverse opioid overdoses, thereby reducing fatalities associated with opioid misuse.

Key Provisions

  • Eligibility Requirements: The bill specifies which individuals or entities are required to acquire and possess opioid antagonists. While the exact criteria are not detailed in the provided information, it typically includes healthcare providers, emergency responders, and potentially educational institutions.

  • Acquisition and Possession: The bill mandates that eligible persons or entities must not only acquire but also maintain a supply of opioid antagonists. This provision ensures that these life-saving drugs are readily available in critical situations.

  • Training and Education: Although not explicitly mentioned in the provided text, similar legislation often includes provisions for training on how to use opioid antagonists effectively. This could involve training for staff in schools, community organizations, and healthcare settings.

Who Would Be Affected

  • Healthcare Providers: Doctors, nurses, and other medical professionals may be required to have opioid antagonists on hand.
  • Emergency Responders: Paramedics and first responders would be included to ensure they can provide immediate assistance in overdose situations.
  • Educational Institutions: Schools and universities may be required to stock opioid antagonists, promoting safety among students.
  • Community Organizations: Non-profits and community health organizations may also fall under this requirement, enhancing community-level responses to opioid overdoses.

Procedural Aspects

  • Current Status: As of March 3, 2025, the bill has been referred to the Health Committee for further discussion and potential amendments.
  • Related Legislation: The bill is connected to several prior-session bills (A 10187, A 448, A 576, S 9583) and has a companion bill (A 1748), indicating ongoing legislative efforts to combat opioid misuse and enhance public health responses.

Conclusion

Bill S 5786 represents a proactive approach to mitigating the opioid crisis by ensuring that key individuals and organizations are equipped with opioid antagonists. By mandating the acquisition and possession of these life-saving medications, the bill seeks to improve emergency responses to opioid overdoses and ultimately save lives. Further discussions in the Health Committee will clarify the specifics of implementation and compliance.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.